October 13 (SeeNews) - Slovenian drug maker Krka on Tuesday said its German subsidiary, TAD Pharma, will pay 2.8 million euro ($4.2 million) in damages for selling the Zalasta drug in Germany without holding the patent for the drug's active ingredient.